Title |
Allosteric function and dysfunction of the prion protein
|
---|---|
Published in |
Cellular and Molecular Life Sciences, October 2011
|
DOI | 10.1007/s00018-011-0847-7 |
Pubmed ID | |
Authors |
Rafael Linden, Yraima Cordeiro, Luis Mauricio T. R. Lima |
Abstract |
Transmissible spongiform encephalopathies (TSEs) are neurodegenerative diseases associated with progressive oligo- and multimerization of the prion protein (PrP(C)), its conformational conversion, aggregation and precipitation. We recently proposed that PrP(C) serves as a cell surface scaffold protein for a variety of signaling modules, the effects of which translate into wide-range functional consequences. Here we review evidence for allosteric functions of PrP(C), which constitute a common property of scaffold proteins. The available data suggest that allosteric effects among PrP(C) and its partners are involved in the assembly of multi-component signaling modules at the cell surface, impose upon both physiological and pathological conformational responses of PrP(C), and that allosteric dysfunction of PrP(C) has the potential to entail progressive signal corruption. These properties may be germane both to physiological roles of PrP(C), as well as to the pathogenesis of the TSEs and other degenerative/non-communicable diseases. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Malaysia | 1 | 2% |
Spain | 1 | 2% |
France | 1 | 2% |
Unknown | 61 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 14 | 22% |
Student > Ph. D. Student | 13 | 20% |
Student > Bachelor | 10 | 16% |
Student > Master | 6 | 9% |
Professor | 5 | 8% |
Other | 12 | 19% |
Unknown | 4 | 6% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 23 | 36% |
Biochemistry, Genetics and Molecular Biology | 14 | 22% |
Neuroscience | 9 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 8% |
Medicine and Dentistry | 4 | 6% |
Other | 5 | 8% |
Unknown | 4 | 6% |